This trial was to see if longer but less intensive chemotherapy worked as well as standard chemotherapy for acute promyelocytic leukaemia (APML). And to see if adding a drug called gemtuzumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback